Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

334
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of high-intensity interval training in patients with chronic hepatitis B and hepatic steatosis: A randomised controlled trial.

PloS one·2026
Same author

Understanding Surgery Refusal in Patients with Colorectal Liver Metastases.

Journal of gastrointestinal cancer·2026
Same author

[Late sequelae after gastrointestinal surgery in adults].

Ugeskrift for laeger·2026
Same author

Quality of Life in Patients With Primary Sclerosing Cholangitis.

Gastro hep advances·2026
Same author

Preoperative Quality of Life as Predictor of Postoperative Early Recurrence and Overall Survival in Patients with Pancreatic and Periampullary Adenocarcinoma.

Journal of gastrointestinal cancer·2026
Same author

Markers of inflammation and lung function in liver transplant recipients: results from a nationwide cohort study.

Frontiers in immunology·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Related Experiment Video

Updated: May 9, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.1K

[Hepatocellular adenomas].

Hans-Christian Pommergaard1,2, Henning Grønbæk3,4, Eva Fallentin5

  • 1Afdeling for Transplantation og Sygdomme i Fordøjelsessystemet, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for Laeger
|May 1, 2025
PubMed
Summary
This summary is machine-generated.

Hepatocellular adenomas, benign liver tumors, pose risks of bleeding and cancer. Management strategies for these liver tumors depend on patient factors and adenoma characteristics.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K

Related Experiment Videos

Last Updated: May 9, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.1K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K

Area of Science:

  • Hepatology
  • Gastroenterology
  • Oncology

Background:

  • Hepatocellular adenomas are benign liver tumors with potential for severe complications.
  • Risk factors for bleeding and malignant transformation include gender, size, and specific subtypes.

Purpose of the Study:

  • To review the diagnosis and treatment of hepatocellular adenomas.
  • To outline management strategies based on individual risk profiles.

Main Methods:

  • Review of existing literature on hepatocellular adenoma diagnosis and treatment.
  • Analysis of risk factors influencing management decisions.

Main Results:

  • Treatment decisions are guided by risk stratification and clinical presentation.
  • Hormone therapy cessation is an initial recommended step.
  • Surgical intervention is advised for all male patients and for female patients with adenomas larger than 5 cm, considering molecular and clinical factors.

Conclusions:

  • Tailored treatment approaches are essential for hepatocellular adenomas.
  • Management should integrate patient-specific risks and adenoma characteristics for optimal outcomes.